News Snapshot:
YishengBio seeks greenlight for Hong Kong IPO By Jonathan Breen 07.45 AM China’s YishengBio is planning to list in Hong Kong, having filed an IPO application with the bourse on Monday. YishengBio has hired Haitong International and Morgan Stanley as the sponsors for the deal. The issuer is a Beijing-headquartered, global biopharmaceutical company that focuses on developing, making and selling new vaccines and therapies for infectious diseases and cancer. It has so far generated revenue from its rabies vaccine ... Already a subscriber? Login